Peter Hamar, MD, PhD, is a full professor at Semmelweis University. His scientific interest is to understand novel mechanisms induced by modulated electro-hyperthermia in triple-negative breast cancer. Furthermore, initiating from a strong background in renal transplantation, he is currently trying to identify key mechanisms of post-ischemic renal fibrosis. Besides being a PI at Semmelweis, P. Hamar intensely collaborates with several research groups including the Immune Disease Institute at Harvard Medical School, Boston, USA. This group was the first to harness RNA interference for the kidney (PNAS), they have also demonstrated the endosomal escape of siRNA from lipid nanoparticles with high-resolution microscopy (Nat Genet). P. Hamar has co-authored